News
MicroPort® NeuroTech Participates in 2021 OCIN as Tubridge® Used in Over 5,000 Clinical Cases - 04 Nov 2021
MicroPort® NeuroTech recently participated in the 2021 Oriental Confer...Top-tier Surgical Robot Company MicroPort MedBot Debuts on Main Board of HKEX - 02 Nov 2021
Shanghai MicroPort® MedBot (Group) Co., Ltd. (02252.HK, “MicroPort Med...MicroPort® MedBot Enters into Strategic Cooperation Agreement with South China Hospital affiliated to Shenzhen University - 02 Nov 2021
MicroPort® MedBot recently held a signing ceremony to mark the strateg...MicroPort® Toumai® Successfully Performed Difficult Procedures for Registered Multidisciplinary Clinical Trials - 01 Nov 2021
Lanzhou, China, 1 November 2021 - Shanghai MicroPort MedBot (Group) Co...MicroPort® MedBot Attends CUA 2021 with MicroPort® Urocare - 01 Nov 2021
MicroPort® MedBot and MicroPort Urocare joined together at the 28th Ch...MicroPort® Presents Argus OCT at the 32nd GW-ICC Entering the Era of Precision PCI - 01 Nov 2021
MicroPort® recently joined the 32nd GW-ICC to present the Argus intrav...MicroPort® CardioFlow Medtech Launches VitaFlow Liberty™ at China Structural Week - 31 Oct 2021
MicroPort CardioFlow Medtech Corporation (CardioFlow Medtech) recently...MicroPort® Makes Strategic Investment in Intravascular Imaging Start-up Argus - 29 Oct 2021
To Strengthen Multi-dimensional Layout of Precision Medicine in Pan-va...MicroPort® Expands MIH in Suzhou Industrial Park to Build Strategic Strength for Original Innovation of High-Tech Medical Solutions - 27 Oct 2021
MicroPort Institute of Health (MIH), a division of MicroPort Scientifi...MicroPort® Hosts Teleconference of TARGET PREMIER Study on Next Generation Rapamycin Target Eluting Stent - 26 Oct 2021
Researchers met remotely in a recent teleconference for the TARGET PRE...Endovastec™ Debuts at Pan-American Congress on Vascular and Endovascular Surgery - 23 Oct 2021
Shanghai MicroPort Endovascular MedTech Co., Ltd. (Endovastec™) recent...MicroPort® CRM Announces Completion of Patient Recruitment for the Primary Objectives of the Apollo Study on Invicta Defibrillation Lead - 23 Oct 2021
MicroPort CRM today announced the completion of patient recruitment in...MicroPort® Toumai® Laparoscopic Surgery Robot's Clinical Trials - 20 Oct 2021
The multi-center clinical trial, ‘Robotic-assisted thoracic, abdominal...Clinical Trial Enrollment Completed for the First Endovastec™ Venous Stent - 17 Oct 2021
Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd. (Endovastec™) ...MicroPort® Shared Latest Research Results at China Heart Congress (CHC) and 6th China Vascular Congress (CVC) - 13 Oct 2021
Recently, Shanghai MicroPort Medical (Group) Co., Ltd. (MicroPort®) pr...MicroPort® Orthopedics Receives FDA 510(k) Approval for Two Hip Products - 09 Oct 2021
The Dynasty® Dual Mobility Acetabular Liners and the E-Class® Vitamin ...